久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/08/20 | 4,256 | 4,296 | 4,240 | 4,282 | -16 | -0.4% | 177,000 |
| 2025/08/19 | 4,266 | 4,298 | 4,264 | 4,298 | +32 | +0.8% | 181,500 |
| 2025/08/18 | 4,263 | 4,312 | 4,259 | 4,266 | +3 | +0.1% | 172,300 |
| 2025/08/15 | 4,370 | 4,370 | 4,246 | 4,263 | -68 | -1.6% | 143,900 |
| 2025/08/14 | 4,334 | 4,380 | 4,331 | 4,331 | -5 | -0.1% | 156,900 |
| 2025/08/13 | 4,290 | 4,351 | 4,289 | 4,336 | +29 | +0.7% | 150,900 |
| 2025/08/12 | 4,271 | 4,328 | 4,260 | 4,307 | +7 | +0.2% | 151,600 |
| 2025/08/08 | 4,213 | 4,300 | 4,209 | 4,300 | +46 | +1.1% | 183,500 |
| 2025/08/07 | 4,212 | 4,269 | 4,183 | 4,254 | +19 | +0.4% | 100,400 |
| 2025/08/06 | 4,167 | 4,266 | 4,167 | 4,235 | +68 | +1.6% | 169,600 |
| 2025/08/05 | 4,109 | 4,172 | 4,101 | 4,167 | +58 | +1.4% | 155,300 |
| 2025/08/04 | 4,085 | 4,137 | 4,070 | 4,109 | +5 | +0.1% | 148,200 |
| 2025/08/01 | 4,063 | 4,117 | 4,049 | 4,104 | +41 | +1% | 156,100 |
| 2025/07/31 | 4,036 | 4,092 | 4,024 | 4,063 | +38 | +0.9% | 276,500 |
| 2025/07/30 | 4,018 | 4,048 | 3,995 | 4,025 | -23 | -0.6% | 680,500 |
| 2025/07/29 | 3,989 | 4,058 | 3,983 | 4,048 | +55 | +1.4% | 236,100 |
| 2025/07/28 | 3,970 | 4,016 | 3,970 | 3,993 | +11 | +0.3% | 116,400 |
| 2025/07/25 | 4,005 | 4,010 | 3,975 | 3,982 | -1 | ±0% | 199,800 |
| 2025/07/24 | 3,999 | 4,020 | 3,967 | 3,983 | +27 | +0.7% | 248,900 |
| 2025/07/23 | 3,950 | 3,987 | 3,925 | 3,956 | -50 | -1.2% | 375,100 |
| 2025/07/22 | 4,036 | 4,065 | 3,997 | 4,006 | -30 | -0.7% | 167,200 |
| 2025/07/18 | 4,019 | 4,056 | 4,002 | 4,036 | +17 | +0.4% | 152,400 |
| 2025/07/17 | 3,950 | 4,063 | 3,950 | 4,019 | +55 | +1.4% | 203,500 |
| 2025/07/16 | 3,914 | 3,977 | 3,908 | 3,964 | +50 | +1.3% | 200,300 |
| 2025/07/15 | 3,942 | 3,989 | 3,902 | 3,914 | -4 | -0.1% | 224,500 |
| 2025/07/14 | 3,925 | 3,935 | 3,887 | 3,918 | -18 | -0.5% | 283,500 |
| 2025/07/11 | 3,948 | 3,957 | 3,861 | 3,936 | -91 | -2.3% | 549,600 |
| 2025/07/10 | 4,012 | 4,027 | 3,961 | 4,027 | -26 | -0.6% | 327,300 |
| 2025/07/09 | 4,023 | 4,078 | 3,999 | 4,053 | +48 | +1.2% | 218,900 |
| 2025/07/08 | 3,992 | 4,021 | 3,964 | 4,005 | -5 | -0.1% | 223,400 |
| 2025/07/07 | 4,000 | 4,018 | 3,986 | 4,010 | +8 | +0.2% | 124,300 |
| 2025/07/04 | 4,001 | 4,010 | 3,971 | 4,002 | +4 | +0.1% | 121,300 |
| 2025/07/03 | 3,993 | 3,999 | 3,956 | 3,998 | -5 | -0.1% | 147,600 |
| 2025/07/02 | 4,012 | 4,060 | 4,003 | 4,003 | -18 | -0.4% | 128,600 |
| 2025/07/01 | 4,075 | 4,093 | 4,021 | 4,021 | -83 | -2% | 131,300 |
| 2025/06/30 | 4,060 | 4,120 | 4,055 | 4,104 | +54 | +1.3% | 146,300 |
| 2025/06/27 | 4,038 | 4,053 | 4,016 | 4,050 | +2 | ±0% | 162,000 |
| 2025/06/26 | 4,057 | 4,089 | 4,033 | 4,048 | -26 | -0.6% | 160,100 |
| 2025/06/25 | 4,040 | 4,078 | 3,993 | 4,074 | +14 | +0.3% | 192,000 |
| 2025/06/24 | 4,109 | 4,118 | 4,052 | 4,060 | ±0 | ±0% | 160,800 |
| 2025/06/23 | 4,095 | 4,113 | 4,051 | 4,060 | -65 | -1.6% | 149,400 |
| 2025/06/20 | 4,174 | 4,179 | 4,125 | 4,125 | -57 | -1.4% | 412,100 |
| 2025/06/19 | 4,255 | 4,275 | 4,164 | 4,182 | -87 | -2% | 94,300 |
| 2025/06/18 | 4,265 | 4,289 | 4,254 | 4,269 | +9 | +0.2% | 109,300 |
| 2025/06/17 | 4,279 | 4,295 | 4,246 | 4,260 | -38 | -0.9% | 85,000 |
| 2025/06/16 | 4,372 | 4,387 | 4,278 | 4,298 | -51 | -1.2% | 99,800 |
| 2025/06/13 | 4,285 | 4,350 | 4,256 | 4,349 | +66 | +1.5% | 174,000 |
| 2025/06/12 | 4,200 | 4,335 | 4,200 | 4,283 | +76 | +1.8% | 181,900 |
| 2025/06/11 | 4,215 | 4,250 | 4,201 | 4,207 | +33 | +0.8% | 117,800 |
| 2025/06/10 | 4,186 | 4,197 | 4,140 | 4,174 | -14 | -0.3% | 176,800 |
1～
50
件表示中 / 3766件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | - | +5.8% | +1.2% | - | - | - |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | - | -11.0% | +206.6% | - | - | - |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 参天薬 | - | -2.0% | -7.3% | - | - | - |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ツムラ | - | +3.8% | -19.9% | - | - | - |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | - | +3.6% | -15.3% | - | - | - |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
該当銘柄がありません
チャート関連のコラム
